Monica A. Slavin

24.1k total citations · 4 hit papers
389 papers, 11.8k citations indexed

About

Monica A. Slavin is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Monica A. Slavin has authored 389 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 252 papers in Epidemiology, 228 papers in Infectious Diseases and 114 papers in Oncology. Recurrent topics in Monica A. Slavin's work include Antifungal resistance and susceptibility (181 papers), Fungal Infections and Studies (137 papers) and Neutropenia and Cancer Infections (79 papers). Monica A. Slavin is often cited by papers focused on Antifungal resistance and susceptibility (181 papers), Fungal Infections and Studies (137 papers) and Neutropenia and Cancer Infections (79 papers). Monica A. Slavin collaborates with scholars based in Australia, United States and France. Monica A. Slavin's co-authors include Karin Thursky, Leon J. Worth, Tania C. Sorrell, David C. M. Kong, Wen Chen, Benjamin W. Teh, Raleigh A. Bowden, H. Gary Schoch, Quoc Nguyen and S.C.-A. Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Monica A. Slavin

366 papers receiving 11.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

1995 611 citations Monica A. Slavin et al. profile →
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports

2018 604 citations Monica A. Slavin, David C. M. Kong et al. profile →
Combination Antifungal Therapy for Invasive Aspergillosis

2015 333 citations Haran T. Schlamm, Eric J. Bow et al. profile →
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia

2018 246 citations Johan Maertens, Roger J. M. Brüggemann et al. Journal of Antimicrobial Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica A. Slavin Australia	55	7.5k	7.3k	2.6k	1.2k	854	389	11.8k
Andreas H. Groll Germany	59	9.6k 1.3×	8.3k 1.1×	1.8k 0.7×	1.5k 1.2×	1.2k 1.4×	288	12.6k
Márcio Nucci Brazil	54	8.1k 1.1×	6.8k 0.9×	1.7k 0.6×	695 0.6×	804 0.9×	237	11.6k
J. Peter Donnelly Netherlands	50	6.6k 0.9×	6.2k 0.9×	3.5k 1.3×	769 0.6×	937 1.1×	178	12.2k
Emmanuel Roilides Greece	62	10.7k 1.4×	9.3k 1.3×	1.3k 0.5×	1.8k 1.4×	1.3k 1.5×	432	15.8k
Andrew J. Ullmann Germany	44	6.3k 0.8×	6.2k 0.9×	1.6k 0.6×	523 0.4×	923 1.1×	116	8.7k
William J. Steinbach United States	54	10.5k 1.4×	8.6k 1.2×	1.7k 0.6×	1.6k 1.3×	1.2k 1.4×	179	14.1k
Oliver A. Cornely Germany	72	16.5k 2.2×	14.2k 2.0×	3.2k 1.2×	1.5k 1.2×	1.6k 1.9×	546	21.3k
Claudio Viscoli Italy	60	6.4k 0.9×	7.2k 1.0×	4.1k 1.5×	2.9k 2.4×	430 0.5×	301	14.6k
Jo‐Anne H. Young United States	32	3.9k 0.5×	4.8k 0.7×	3.8k 1.5×	647 0.5×	406 0.5×	96	9.0k
Olivier Lortholary France	79	16.3k 2.2×	15.9k 2.2×	1.6k 0.6×	1.2k 1.0×	1.8k 2.1×	482	23.6k

Countries citing papers authored by Monica A. Slavin

Since Specialization

Citations

This map shows the geographic impact of Monica A. Slavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica A. Slavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica A. Slavin more than expected).

Fields of papers citing papers by Monica A. Slavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica A. Slavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica A. Slavin. The network helps show where Monica A. Slavin may publish in the future.

Co-authorship network of co-authors of Monica A. Slavin

This figure shows the co-authorship network connecting the top 25 collaborators of Monica A. Slavin. A scholar is included among the top collaborators of Monica A. Slavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica A. Slavin. Monica A. Slavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberts, Jason A., Fekade B. Sime, Jeffrey Lipman, et al.. (2025). Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study. Intensive Care Medicine. 51(2). 302–317. 11 indexed citations

Dendle, Claire, Monica A. Slavin, Robert Weinkove, et al.. (2024). Neutropenic Sepsis in the Intensive Care Unit: Differences in Clinical Profile and Outcomes According to the Cause of Neutropenia. Open Forum Infectious Diseases. 11(6). ofae289–ofae289. 1 indexed citations

Maertens, Johan, Monica A. Slavin, Martin Hoenigl, et al.. (2024). Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate. Journal of Antimicrobial Chemotherapy. 79(8). 1786–1793. 2 indexed citations

Saharia, Kapil, Andrew H. Karaba, Nancy Law, et al.. (2024). Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey. Transplant Infectious Disease. 26(5). e14342–e14342. 2 indexed citations

Liu, Alice, Monica A. Slavin, Simon J. Harrison, & Benjamin W. Teh. (2024). Infections during novel myeloma therapies. Leukemia & lymphoma. 66(3). 420–432. 1 indexed citations

Neoh, Chin Fen, Sharon C.‐A. Chen, Fanny Lanternier, et al.. (2024). Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections. Clinical Microbiology Reviews. 37(2). e0000423–e0000423. 17 indexed citations

Teh, Benjamin W., Gemma Reynolds, Małgorzata Mikulska, Nicolas J. Mueller, & Monica A. Slavin. (2024). Improving infection reporting in hematology treatment trials. Blood Advances. 8(22). 5925–5926. 2 indexed citations

Reynolds, Gemma, Tim Spelman, Mary Ann Anderson, et al.. (2023). Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 192. 104134–104134. 14 indexed citations

Stewart, Adam G., Sharon C.-A. Chen, Kate Hamilton, et al.. (2023). Clostridioides difficileInfection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia. Open Forum Infectious Diseases. 10(6). ofad232–ofad232.

10.

Lindsay, Julian, Elizabeth M. Krantz, Jessica Morris, et al.. (2022). Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center. Transplantation and Cellular Therapy. 28(8). 511.e1–511.e10. 10 indexed citations

11.

Lindsay, Julian, Jad Othman, Sebastiaan J. van Hal, et al.. (2021). SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases. 8(11). ofab502–ofab502. 11 indexed citations

12.

Lindsay, Julian, Ian Kerridge, Tracey O’Brien, et al.. (2021). Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report. Transplantation and Cellular Therapy. 27(9). 798.e1–798.e10. 21 indexed citations

13.

Slavin, Monica A., et al.. (2020). Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring. Expert Review of Anti-infective Therapy. 19(6). 707–718. 14 indexed citations

14.

Paige, Emma, Leon J. Worth, Karin Thursky, et al.. (2019). Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program. Leukemia & lymphoma. 60(10). 2373–2383. 11 indexed citations

15.

Teh, Benjamin W., et al.. (2017). Impact of a dedicated post-transplant vaccination service at an Australian cancer centre. Bone Marrow Transplantation. 52(12). 1681–1683. 10 indexed citations

16.

Bow, Eric J., David J. Vanness, Monica A. Slavin, et al.. (2015). Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. BMC Infectious Diseases. 15(1). 128–128. 44 indexed citations

17.

Slavin, Monica A., Karin Thursky, Leon J. Worth, et al.. (2014). Introduction to the updatedAustralian andNewZealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014. Internal Medicine Journal. 44(12b). 1267–1276. 15 indexed citations

18.

Turner, Stuart, Sharon C.‐A. Chen, Monica A. Slavin, & David C. M. Kong. (2013). Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients. Expert Review of Pharmacoeconomics & Outcomes Research. 13(2). 227–235. 7 indexed citations

19.

Lingaratnam, Senthil, Monica A. Slavin, Bogda Koczwara, et al.. (2011). Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Internal Medicine Journal. 41(1b). 75–81. 29 indexed citations

20.

Blyth, Christopher C., Wen Chen, Monica A. Slavin, et al.. (2009). Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients. PEDIATRICS. 123(5). 1360–1368. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact